<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells</dc:title>
  <dc:creator>Jaimovich, E.</dc:creator>
  <dc:creator>Mattei, C.</dc:creator>
  <dc:creator>Liberona, J. L.</dc:creator>
  <dc:creator>Cardenas, C.</dc:creator>
  <dc:creator>Estrada, M.</dc:creator>
  <dc:creator>Barbier, J.</dc:creator>
  <dc:creator>/Debitus, C&#xE9;cile</dc:creator>
  <dc:creator>/Laurent, Dominique</dc:creator>
  <dc:creator>Molgo, J.</dc:creator>
  <dc:subject>INVERTEBRE AQUATIQUE</dc:subject>
  <dc:subject>SUBSTANCE NATURELLE</dc:subject>
  <dc:subject>ALCALOIDE</dc:subject>
  <dc:subject>STRUCTURE CHIMIQUE</dc:subject>
  <dc:subject>ACTIVITE BIOLOGIQUE</dc:subject>
  <dc:subject>INTERET PHARMACOLOGIQUE</dc:subject>
  <dc:subject>CULTURE CELLULAIRE</dc:subject>
  <dc:subject>TEST</dc:subject>
  <dc:subject>XESTOSPONGIN B</dc:subject>
  <dc:subject>EPONGE</dc:subject>
  <dc:subject>xestospongin B</dc:subject>
  <dc:subject>inositol 1,4,5 trisphosphate</dc:subject>
  <dc:subject>intracellular Ca2+ signals</dc:subject>
  <dc:subject>bradykinin</dc:subject>
  <dc:subject>neuroblastoma NG108 15 cell</dc:subject>
  <dc:subject>rat skeletal myotubes</dc:subject>
  <dc:subject>cerebellar membranes</dc:subject>
  <dc:subject>isolated myonuclei</dc:subject>
  <dc:subject>calcium ATPase</dc:subject>
  <dc:description>Xestospongin B, a macrocyclic bis-1-oxaquinolizidine alkaloid extracted from the marine sponge Xestospongia exigua, was highly purified and tested for its ability to block inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release. In a concentration-dependent manner xestospongin B displaced [H-3]IP3 from both rat cerebellar membranes and rat skeletal myotube homogenates with an EC50 of 44.6 +/- 1.1 mu M and 27.4 +/- 1.1 mu M, respectively. Xestospongin B, depending on the dose, suppressed bradykinin-induced Ca2+ signals in neuroblastoma (NG108-15) cells, and also selectively blocked the slow intracellular Ca2+ signal induced by membrane depolarization with high external K+ (47mM) in rat skeletal myotubes. This slow Ca2+ signal is unrelated to muscle contraction, and involves IP3 receptors. In highly purified isolated nuclei from rat skeletal myotubes, Xestospongin B reduced, or suppressed IP3-induced Ca2+ oscillations with an EC50 = 18.9 +/- 1.35 mu M. In rat my rotubes exposed to a Ca2+-free medium, Xestospongin B neither depleted sarcoplasmic reticulum Ca2+ stores, nor modified thapsigargin action and did not affect capacitative Ca2+ entry after thapsigargin-induced depletion of Ca2+ stores. Ca2+-ATPase activity measured in skeletal myrotube homogenates remained unaffected by Xestospongin B. It is concluded that xestospongin B is an effective cell-permeant. competitive inhibitor of IP3 receptors in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.</dc:description>
  <dc:date>2005</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010038253</dc:identifier>
  <dc:identifier>fdi:010038253</dc:identifier>
  <dc:identifier>Jaimovich E., Mattei C., Liberona J. L., Cardenas C., Estrada M., Barbier J., Debitus C&#xE9;cile, Laurent Dominique, Molgo J.. Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. 2005, 579 (10),  2051-2057</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>NOUVELLE CALEDONIE</dc:coverage>
</oai_dc:dc>
